Edition:
United Kingdom

Towa Pharmaceutical Co Ltd (4553.T)

4553.T on Tokyo Stock Exchange

6,110JPY
17 Nov 2017
Change (% chg)

¥20 (+0.33%)
Prev Close
¥6,090
Open
¥6,070
Day's High
¥6,150
Day's Low
¥6,020
Volume
65,000
Avg. Vol
42,308
52-wk High
¥6,230
52-wk Low
¥4,015

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 22,185.00 129.552
Jun 22,513.00 113.076
FY 2017 Mar '17 21,248.00 43.447
Dec 23,180.00 266.158
Sep 20,344.00 62.021
Jun 20,177.00 -67.000
FY 2016 Mar '16 20,881.00 77.493
Dec 22,072.00 128.987
Sep 19,732.00 99.057
Jun 19,430.00 131.802
FY 2015 Mar '15 18,415.00 130.214
Dec 19,587.00 284.610
Sep 16,982.00 163.928
Jun 16,486.00 75.433
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-17 1 21,979.00 21,979.00 21,979.00 --
Quarter Ending Mar-18 2 23,251.00 23,702.00 22,800.00 --
Year Ending Mar-17 4 86,625.00 89,000.00 85,000.00 --
Year Ending Mar-18 5 93,700.00 94,000.00 93,500.00 98,560.00
Year Ending Mar-19 5 98,380.00 99,000.00 97,000.00 105,350.00
Earnings (per share)
Year Ending Mar-17 5 254.24 329.21 182.90 --
Year Ending Mar-18 6 382.34 438.90 359.69 433.66
Year Ending Mar-19 6 362.74 378.00 347.50 436.98
Sales and Profit Figures in Japanese Yen (JPY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 11.74 31.15 32.96
P/E High - Last 5 Yrs. 17.92 40.78 45.57
P/E Low - Last 5 Yrs. 10.50 23.79 24.35
Beta 0.73 0.90 0.89
Price to Sales (TTM) 1.12 3.94 5.25
Price to Book (MRQ) 1.23 4.83 5.40
Price to Tangible Book (MRQ) 1.32 5.47 6.73
Price to Cash Flow (TTM) 5.83 23.18 23.58
% Owned Institutions -- 0.77 1.29

Dividends

  Company industry sector
Dividend Yield 1.67 1.54 1.48
Dividend Yield - 5 Year Avg 1.64 1.54 1.49
Dividend 5 Year Growth Rate 6.30 4.38 5.23
Payout Ratio(TTM) 17.95 45.05 43.12

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 11.58 3.32 8.84
Sales (TTM) vs TTM 1 Yr. Ago 5.34 4.75 5.41
Sales - 5 Yr. Growth Rate 11.76 10.23 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 268.77 16.20 19.37
EPS (TTM) vs TTM 1 Yr. Ago 103.20 -- --
EPS - 5 Yr. Growth Rate -1.24 10.04 10.96
Capital Spending - 5 Yr. Growth Rate 17.68 15.37 15.32

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.35 2.12 2.20
Current Ratio (MRQ) 2.45 2.91 3.00
LT Debt to Equity (MRQ) 70.54 8.63 10.82
Total Debt to Equity (MRQ) 76.52 12.47 14.95
Interest Coverage (TTM) -- 37.12 33.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 45.76 54.92 54.68
Gross Margin - 5 Yr. Avg. 49.52 52.01 52.15
EBITD Margin (TTM) 18.32 -- --
EBITD - 5 Yr. Avg 21.37 18.41 15.51
Operating Margin (TTM) 9.48 14.62 9.27
Operating Margin - 5 Yr. Avg. 13.08 14.52 11.18
Pre-Tax Margin (TTM) 12.42 15.10 10.08
Pre-Tax Margin - 5 Yr. Avg. 14.18 14.85 11.61
Net Profit Margin (TTM) 9.94 11.35 6.37
Net Profit Margin - 5 Yr. Avg. 10.30 11.16 7.88
Effective Tax Rate (TTM) 19.93 23.30 23.20
Effective Tax Rate - 5 Yr. Avg. 27.38 23.46 24.03

Efficiency

  Company industry sector
Revenue/Employee (TTM) 36,247,920 967,481,775 876,721,579
Net Income/Employee (TTM) 3,604,651 113,847,942 103,151,091
Receivable Turnover (TTM) 3.38 5.62 5.78
Inventory Turnover (TTM) 1.22 2.58 3.35
Asset Turnover (TTM) 0.54 0.96 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 5.40 11.53 11.10
Return on Assets - 5 Yr. Avg. 6.15 13.15 12.57
Return on Investment (TTM) 6.81 14.99 14.58
Return on Investment - 5 Yr. Avg. 7.94 17.20 16.46
Return on Equity (TTM) 11.97 16.33 16.09
Return on Equity - 5 Yr. Avg. 11.46 18.16 17.62
  1 Year 3 Year 5 Year
Sales % 3.45 11.46 11.76
EPS (TTM) % -27.98 -3.76 -1.24
Dividend % 0.00 8.20 6.30
Note: Units in Millions of US Dollars

Performance for Towa Pharmaceutical Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 10.27 4.15 83 25
13 Week 11.57 6.27 82 36
26 Week 3.45 -8.65 65 30
52 Week 37.44 10.29 79 12
YTD 24.24 11.82 75 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 24.56%
# of Holders: 69
Total Shares Held: 4,217,152
3 Mo. Net Change: 106,643
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 13
# Reduced Positions: 13
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.